
Calumet, Inc. (NASDAQ:CLMT – Free Report) – Equities research analysts at HC Wainwright boosted their Q1 2026 EPS estimates for Calumet in a note issued to investors on Monday, March 30th. HC Wainwright analyst A. Dayal now expects that the oil and gas company will post earnings of ($0.61) per share for the quarter, up from their prior estimate of ($0.63). HC Wainwright has a “Buy” rating and a $60.00 price target on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s Q2 2026 earnings at ($0.59) EPS, Q3 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($1.76) EPS and FY2027 earnings at $1.07 EPS.
A number of other brokerages have also recently weighed in on CLMT. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. The Goldman Sachs Group lifted their target price on shares of Calumet from $24.00 to $34.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Wall Street Zen downgraded Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. TD Cowen raised their price target on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, March 5th. Finally, UBS Group restated a “neutral” rating and set a $26.00 price objective on shares of Calumet in a research note on Friday, February 13th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $30.17.
Calumet Stock Up 2.5%
Shares of NASDAQ CLMT opened at $35.90 on Wednesday. The stock has a market capitalization of $3.12 billion, a PE ratio of -92.05 and a beta of 1.18. The firm has a fifty day moving average of $27.36 and a 200-day moving average of $22.12. Calumet has a 52-week low of $7.68 and a 52-week high of $36.94.
Calumet (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The company had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.04 billion. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period in the prior year, the business earned ($0.47) EPS.
Institutional Trading of Calumet
A number of institutional investors and hedge funds have recently made changes to their positions in CLMT. Islay Capital Management LLC acquired a new position in Calumet during the 4th quarter valued at approximately $25,000. Aster Capital Management DIFC Ltd increased its position in Calumet by 294.7% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after buying an additional 1,229 shares during the period. Global Retirement Partners LLC acquired a new stake in Calumet in the fourth quarter worth $34,000. Covestor Ltd lifted its stake in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after buying an additional 492 shares during the last quarter. Finally, CWM LLC boosted its holdings in shares of Calumet by 149,900.0% during the fourth quarter. CWM LLC now owns 3,000 shares of the oil and gas company’s stock valued at $60,000 after acquiring an additional 2,998 shares during the period. 34.41% of the stock is currently owned by institutional investors and hedge funds.
Calumet News Roundup
Here are the key news stories impacting Calumet this week:
- Positive Sentiment: HC Wainwright raised the firm’s price target to $60 and reiterated a “Buy” rating, arguing improved 2026/2027 earnings prospects and implying significant upside from current levels. Benzinga
- Positive Sentiment: The analyst materially upgraded EPS forecasts across 2026 quarters (Q1 to ($0.61) from ($0.63); Q2 to ($0.59) from ($0.63); Q3 to ($0.26) from ($0.51); Q4 to ($0.30) from ($0.54)) and lifted FY2026 to ($1.76) from ($2.32). Importantly, FY2027 is now modeled at $1.07 (previously a loss), signaling a projected return to profitability that supports a higher valuation. Analyst Note Coverage
- Positive Sentiment: Market reaction: reports note a strong intraday move on above‑average volume (Zacks highlighted a ~12% jump in the prior session), indicating the upgrade and estimate revisions are being priced in by traders. Zacks
- Neutral Sentiment: Post‑surge valuation is under review: coverage (Yahoo Finance) examines whether the recent run already reflects the improved outlook, which could limit near‑term upside if multiples re‑rate quickly. Yahoo Finance
- Negative Sentiment: Risk remains: the street consensus still shows a multi‑quarter loss profile (consensus FY current year around ($3.02) EPS), so execution risk and sensitivity to oil/refining margins mean the stock could reverse if underlying results or commodity trends disappoint.
Calumet Company Profile
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Recommended Stories
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
